The seventh edition of the Indian Pharmacopoeia (IP 2014) is published by the Indian Pharmacopoeia Commission (IPC) on behalf of the Government of India, Ministry of Health & Family Welfare. The Indian Pharmacopoeia (IP) is published in fulfilment of the requirements of the Drugs and Cosmetics Act, 1940 and Rules thereunder. It prescribes the standards for drugs produced and/or marketed in India and thus contributes in the control and assurance of the quality of the medicines. The standards of this pharmacopoeia are authoritative and legally enforceable. It intends to help in the licensing of manufacturing units, inspection and distribution of medicines.
IP is published in continuing pursuit of the mission of IPC to improve the health of the people through ensuring the quality, safety and efficacy of medicines. The Commission has been receiving significant inputs from regulatory, industrial houses, academic institutions, national laboratories, individual scientists and others. Publication of IP at regular and shorter intervals is one of the main mandates of the Commission.
The seventh edition of Indian Pharmacopoeia 2014 is published in accordance with the principles and design plan decided by the Scientific Body of the IPC. To establish transparency in setting standards for this edition, the contents of new monographs, revised appendices and other informations have been publicized on the website of the IPC, besides following conventional approach of obtaining comments. The feedback and inputs were reviewed by the relevant Expert Committee to ensure the feasibility and practicability of the standards and methods revised. The principle of “openness, justice and fairness” is kept in mind during compiling and editing the contents of this edition.
The Indian Pharmacopoeia 2014 is presented in four volumes. The scope of the Pharmacopoeia has been extended to include products of biotechnology, indigenous herbs and herbal products, veterinary vaccines and additional antiretroviral drugs and formulations, inclusive of commonly used fixed-dose combinations. Standards for new drugs and drugs used under National Health Programmes are added and the drugs as well as their formulations not in use now a days are omitted from this edition.
The IP 2014 incorporates 2548 monographs of drugs out of which 577 are new monographs consisting of APIs, excipients, dosage forms, antibiotic monographs, insulin products and herbal products etc. 19 New Radiopharmaceutical Monographs and 1 General chapter is first time being included in this edition. It is hoped that this edition would play a significant role in improving the quality of medicines which in turn promote public health and accelerate the growth and development of Pharma Sector.
Press Release of IP 2014
News & Highlights
- Display of result for the post of Principal Scientific Officer (GP Rs. 7600) (Direct Recruitment)
- Vacancy circular for filling up of the vacant post of Jr Materiovigilance Associate in Materiovigilance Programme of India, Indian Pharmacopoeia Commission (IPC)
- Application are invited for 33rd Skill Development Programme on Pharmacovigilance scheduled from 2nd to 6th June 2025.
- Application are invited for Workshop-cum-Training for the staff of NABH accredited hospitals on Pharmacovigilance at Indraprastha Apollo Hospital New Delhi on 30th May 2025.
- Cancellation notice regarding filling up of0 posts (4 posts by Direct Recruitment and 6 posts by Deputation) in IPC
- Notice regarding filling up three vacant posts of Senior Scientific Officer in IPC
- Training Programme on Capacity Building & Strengthening of Materiovigilance Programme of India in North Eastern States.
- Tender for printing and Binding of Indian Pharmacopoeia (IP-2026)
- Applications are invited for Regional Training Programme on "Implementation of PV Guidance Document for MAHs of Pharmaceutical Products, Version 2.0" at Techno India University, Salt Lake, Kolkata, West Bengal on 08th April 2025.
- Extention of Statutory Audit of Annual Accounts of the Indian Pharmacopoeia Commission, Ministry of Health & Family Welfare, Govt. of India
- Public Auction for the Old and obsolete Items at IPC, Ghaziabad
- PT Schedule 2025-2026
- Inviting comments from the stakeholders for the draft IVD-MD adverse event reporting form
- Proposal to Change Titles of IP Monographs
- Indian Pharmacopoeia Commission (IPC) hosted the 15th International Meeting of World Pharmacopoeias (IMWP)
- Empanelment of Publishers/ Suppliers/ Book sellers for supply of Books to Indian Pharmacopoeia Commission (IPC) Library, Ghaziabad, U.P.
- 15th International Meeting of World Pharmacopoeias (IMWP) Inaugurated in New Delhi
- Applications are invited for Regional Training Programme on "Implementation of PV Guidance Document for MAHs of Pharmaceutical Products, Version 2.0" at Central Drugs Testing Laboratory (CDTL) Mumbai on 28th February 2025.
- Last date extended till 30th January, 2025: Register for 15th International Meeting of World Pharmacopoeias (IMWP)
- Call for Experts: Join Subject Expert Committee of Materiovigilance Programme of India
- 17th Foundation Day Celebration of the Indian Pharmacopoeia Commission Ghaziabad
- Circular for filling up of various vacant post in IPC
- Indian Pharmacopoeia 2022- Amendment List 07 to IP 2022
- Application are invited for Regional Training Programme on "Implementation of PV Guidance Document for MAHs of Pharmaceutical Products, Version 2.0" at NIMHANS, Bengaluru on 29th January, 2025.
- Application are invited for Workshop-cum-Training for the staff of NABH accredited hospitals on Pharmacovigilance at Fortis Hospital Mohali Punjab on 31st January 2025.
- Register for 15th International Meeting of World Pharmacopoeias (IMWP) & 2nd Policymakers’ Forum
- Application are invited for 32nd Skill Development Programme on Pharmacovigilance scheduled from 3rd to 7th March 2025.
- Vacancy circular for the post of Human Resource Associate
- Vacancy circular for the post of Jr Associate
- Vacancy circular for the post of Jr Associate
View All